In support of this idea, similar findings were reported previously, where empagliflozin, a selective SGLT2 inhibitor, alleviated mitochondrial damage after myocardial infarction in diabetic rat hearts along with LD accumulation [36]. The gene discussed is SLC5A2; the disease is myocardial infarction.